TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 24, 2026 /PRNewswire/ — Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the Company will participate in the upcoming Morgan Stanley Technology, Media & Telecom Conference. Relevant details include:
|
Date: |
March 3, 2026 |
|
Conference: |
Morgan Stanley Technology, Media & Telecom Conference |
|
Presentation Time: |
10:45 a.m. ET |
|
Format |
Fireside Chat |
|
Event URL: |
|
|
Cellebrite Executives:
|
David Barter, chief financial officer Andrew Kramer, vice president, investor relations |
About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate more than 1.5 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com.
Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760
Media
Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910
Logo – https://mma.prnewswire.com/media/2855183/Cellebrite_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cellebrite-announces-participation-in-the-morgan-stanley-technology-media–telecom-conference-302695104.html
MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…
MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…
SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…
Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…
– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…
- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…